Chronic constipation in adults

Presse Medicale

Volumn 42, Issue 9 PART1, 2013, Pages 1176-1185

  Zeitoun, Jean David ^a,b   de Parades, Vincent ^c  

^a HÔPITAL SAINT ANTOINE   (France)

^b Centre hospitalier Diaconesses Croix Saint Simon   (France)

^c SAINT JOSEPH HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BULKING AGENT; LAXATIVE;

ADULT; CHRONIC DISEASE; CONSERVATIVE TREATMENT; CONSTIPATION; DRUG EFFICACY; FEEDBACK SYSTEM; HUMAN; IDIOPATHIC DISEASE; LIFESTYLE MODIFICATION; PRIMARY MEDICAL CARE; SHORT SURVEY; SURGICAL APPROACH; ALGORITHM; ARTICLE; CLASSIFICATION;

ALGORITHMS; CHRONIC DISEASE; CONSTIPATION; HUMANS; LAXATIVES;

EID: 84884350500     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2012.09.034     Document Type: Short Survey

References (28)

1. Tack J., Müller-Lissner S., Stanghellini V., Boeckxstaens G., Kamm M.A., Simren M., et al. Diagnosis and treatment of chronic constipation: a European perspective. Neurogastroenterol Motil 2011, 23:697-710.
2. McCallum I.J., Ong S., Mercer-Jones M. Chronic constipation in adults. BMJ 2009, 338:b831.
3. Gallegos-Orozco J.F., Foxx-Orenstein A.E., Sterler S.M., Stoa J.M. Chronic constipation in the elderly. Am J Gastroenterol 2012, 107:18-25.
4. Higgins P.D., Johanson J.F. Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol 2004, 99:750-759.
5. Wald A., Scarpignato C., Kamm M.A., Mueller-Lissner S., Helfrich I., Schuijt C., et al. The burden of constipation on quality of life: results of a multinational survey. Aliment Pharmacol Ther 2007, 26:227-236.
6. Sanchez M.I., Bercik P. Epidemiology and burden of chronic constipation. Can J Gastroenterol 2011, 25(Suppl.B):11B-15B.
7. Longstreth G.F., Thompson W.G., Chey W.D., Houghton L.A., Mearin F., Spiller R.C. Functional bowel disorders. Gastroenterology 2006, 130:1480-1491.
8. Piche T., Dapoigny M., Bouteloup C., Chassagne P., Coffin B., Desfourneaux V., et al. Recommendations for the clinical management and treatment of chronic constipation in adults. Gastroenterol Clin Biol 2007, 31:125-135.
9. Bharucha A.E., Wald A.M. Anorectal disorders. Am J Gastroenterol 2010, 105:786-794.
10. Bharucha A.E. Recent advances in functional anorectal disorders. Curr Gastroenterol Rep 2011, 13:316-322.
11. Spiller R., Aziz Q., Creed F., Emmanuel A., Houghton L., Hungin P., et al. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut 2007, 56:1770-1798.
12. Siproudhis L., Eléouet M., Desfourneaux V., Abittan S., Bretagne J.F. Diagnosis of dyschezia. Gastroenterol Clin Biol 2009, 33:F68-F74.
13. Sikirov D. Comparison of straining during defecation in three positions: results and implications for human health. Dig Dis Sci 2003, 48:1201-1205.
14. Suares N.C., Ford A.C. Systematic review: the effects of fibre in the management of chronic idiopathic constipation. Aliment Pharmacol Ther 2011, 33:895-901.
15. Whorwell P.J. The problem of insoluble fibre in irritable bowel syndrome. BMJ 2009, 338:a3149.
16. Ford A.C., Suares N.C. Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis. Gut 2011, 60:209-218.
17. Mueller-Lissner S., Kamm M.A., Wald A., Hinkel U., Koehler U., Richter E., et al. Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of sodium picosulfate in patients with chronic constipation. Am J Gastroenterol 2010, 105:897-903.
18. 4receptor agonists: potential for treatment of gastrointestinal motility disorders. Expert Opin Investig Drugs 2010, 19:765-775.
19. Tack J. Current and future therapies for chronic constipation. Best Pract Res Clin Gastroenterol 2011, 25:151-158.
20. Chey W.D., Drossman D.A., Johanson J.F., Scott C., Panas R.M., Ueno R. Safety and patient outcomes with lubiprostone for up to 52weeks in patients with irritable bowel syndrome with constipation. Aliment Pharmacol Ther 2012, 35:587-599.
21. Lembo A.J., Schneier H.A., Shiff S.J., Kurtz C.B., MacDougall J.E., Jia X.D., et al. Two randomized trials of linaclotide for chronic constipation. N Engl J Med 2011, 365:527-536.
22. McNicol E., Boyce D.B., Schumann R., Carr D. Efficacy and safety of mu-opioid antagonists in the treatment of opioid-induced bowel dysfunction: systematic review and meta-analysis of randomized controlled trials. Pain Med 2008, 9:634-659.
23. Brazzelli M., Griffiths P. Behavioural and cognitive interventions with or without other treatments for the management of faecal incontinence in children. Cochrane Database Syst Rev 2006, 2:CD002240.
24. Faucheron J.L., Voirin D., Badic B. Sacral nerve stimulation for fecal incontinence: causes of surgical revision from a series of 87consecutive patients operated on in a single institution. Dis Colon Rectum 2010, 53:1501-1507.
25. Kamm M.A., Dudding T.C., Melenhorst J., Jarrett M., Wang Z., Buntzen S., et al. Sacral nerve stimulation for intractable constipation. Gut 2010, 59:333-340.
26. Lefèvre J.H., Parc Y., Giraudo G., Bell S., Parc R., Tiret E. Outcome of antegrade continence enema procedures for faecal incontinence in adults. Br J Surg 2006, 93:1265-1269.
27. Lehur P.A., Stuto A., Fantoli M., Villani R.D., Queralto M., Lazorthes F., et al. Outcomes of stapled transanal rectal resection vs. biofeedback for the treatment of outlet obstruction associated with rectal intussusception and rectocele: a multicenter, randomized, controlled trial. Dis Colon Rectum 2008, 51:1611-1618.
28. Heaton K.W., Radvan J., Cripps H., Mountford R.A., Braddon F.E., Hughes A.O. Defecation frequency and timing, and stool form in the general population: a prospective study. Gut 1992, 33:818-824.